The binding capacity to cardiolipin and the functional affinity of affinity-purified anticardiolipin (aCL) IgG of patients with autoimmune disease have been compared with those of individuals with malaria and acquired immunodeficiency syndrome (AIDS). The binding of autoimmune IgG aCL was enhanced gradually by the incorporation of increasing amounts of β2-glycoprotein I (β2GPI) into the assay, in contrast to that of patients with infectious diseases. In addition, there were significant reductions of functional affinity in autoimmune disease, but not in malaria or in AIDS. These results indicate that β2GPI requirement for binding to the target antigen varies inversely with functional affinity in autoimmune disease when β 2GPI was present, and suggest that IgG aCL are more heterogeneous in this type of disorder than in patients with infectious disease.
Harris EN et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet1983; 2: 1211-1214.
2.
Facer CA, Agiostratidou G.High levels of antiphospholipid antibodies in uncomplicated and severe Plasmodium faciparum and in P. vivax malaria. Clin Exp Immunol1994; 95: 304-309.
3.
Stimmler MM et al. Anticardiolipin antibodies in acquire immunodeficiency syndrome . Arch Intern Med1989; 149: 1833-1835.
4.
Hughes Grv.What's going to happen tomorrow in the field of antiphospholipid antibodies . Ann Méd Int1992; 143: 417-418.
5.
Alarcón-Segovia D., Cabral ARFunctional and immunochemical heterogeneity of antiphospholipid antibodies: a classification. J Rheumatol1992; 19: 1166-1169.
6.
McNeil HP et al. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation, β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA1990; 87: 4120-4124.
7.
Galli M. et al. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet1990; 1: 1544-1547.
8.
Matsuura E. et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol1992; 148: 3885-3891.
9.
Pierangeli SS et al. β2-glycoprotein I enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies. Br J Haematol1992; 82: 565-570.
10.
Krilis SAWhat's going to happen tomorrow as far as β2-glycoprotein I is concerned ? Ann Méd Int1995; 146: 212-214.
11.
Costello PB , Green FABinding affinity of serum immunoglobulin G to cardiolipin and another phospholipids in patients with systemic lupus erythematosus and syphilis. Infect Immun1988; 56: 1738-1742.
12.
Devey ME et al. Determination of the functional affinity of IgG, and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays. J Immunol Methods1988; 106: 119-125.
13.
Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271-1277.
14.
Alarc6n-Segovia D., Sánchez-Guerrero J.Primary antiphospholipid syndrome. J Rheumatol1989; 16: 482-489.
15.
Redfield RR , Wright DC, Tramont ECThe Walter Reed staging classification for HTLVIII/LAV infection. N Engl J Med1986; 314: 131-132.
16.
Pennec YL et al. Serial measurements of anticardiolipin antibodies in primary Sjögren's syndrome. Clin Exp Rheumatol1991 ; 9: 165-167.
17.
Youinou P. et al. Antibodies to cardiolipin in ischaemic heart disease. Eur J Intern Med1993; 4: 53-56.
18.
Le Tonquèze M. et al. Role of β2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus1995; 20: 59-66.
19.
Youinou P. et al. Tioipronine-induced reduction of rheumatoid factor functional affinity and asialylated IgG in patients with rheumatoid arthritis. Clin Exp Rheumatol1992; 10: 333-338.
20.
Ichikawa K. et al. β2-glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome . Arthritis Rheum1994; 34: 1453-1461.
21.
Harris EN et al. Anticardiolipin antibodies and binding of anionic phospholipids and serum protein. Lancet1990; 336: 505-506.
Loizou S. et al. Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders . Clin Exp Immunol1992; 90: 434-439.
24.
Shoenfeld Y., Isenberg DANatural Autoantibodies: Their Physiological Role and Regulatory Significance . Boca Raton: CRC Press, 1993.
25.
Harris EN et al. Use of enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J Infect Dis1988 ; 157: 23-31.
